BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28980211)

  • 1. Pathologic Response to Preoperative Therapy as a Novel Prognosticator for Ampullary and Duodenal Adenocarcinoma.
    Yamashita S; Overman MJ; Wang H; Zhao J; Okuno M; Goumard C; Tzeng CW; Kim M; Fleming JB; Vauthey JN; Katz MH; Lee JE; Conrad C
    Ann Surg Oncol; 2017 Dec; 24(13):3954-3963. PubMed ID: 28980211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of Preoperative Therapy on Short- and Long-Term Outcomes of Patients with Adenocarcinoma of the Ampulla of Vater.
    Cloyd JM; Wang H; Overman M; Zhao J; Denbo J; Prakash L; Kim MP; Shroff R; Javle M; Varadhachary GR; Fogelman D; Wolff RA; Koay EJ; Das P; Maitra A; Aloia TA; Vauthey JN; Fleming JB; Lee JE; Katz MHG
    Ann Surg Oncol; 2017 Jul; 24(7):2031-2039. PubMed ID: 28124275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment utilization and surgical outcome of ampullary and duodenal adenocarcinoma.
    Shaib WL; Sharma R; Brutcher E; Kim S; Maithel SK; Chen Z; Kooby DA; Kauh J; Landry J; El-Rayes BF
    J Surg Oncol; 2014 May; 109(6):556-60. PubMed ID: 24338561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors predicting survival and pathological subtype in patients with ampullary adenocarcinoma.
    Okano K; Oshima M; Yachida S; Kushida Y; Kato K; Kamada H; Wato M; Nishihira T; Fukuda Y; Maeba T; Inoue H; Masaki T; Suzuki Y
    J Surg Oncol; 2014 Aug; 110(2):156-62. PubMed ID: 24619853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic relevance of lymph node ratio and number of resected nodes after curative resection of ampulla of Vater carcinoma.
    Falconi M; Crippa S; Domínguez I; Barugola G; Capelli P; Marcucci S; Beghelli S; Scarpa A; Bassi C; Pederzoli P
    Ann Surg Oncol; 2008 Nov; 15(11):3178-86. PubMed ID: 18712568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and comparative outcomes of periampullary cancer: A population-based analysis demonstrating improved outcomes and increased use of adjuvant therapy from 2004 to 2012.
    Hester CA; Dogeas E; Augustine MM; Mansour JC; Polanco PM; Porembka MR; Wang SC; Zeh HJ; Yopp AC
    J Surg Oncol; 2019 Mar; 119(3):303-317. PubMed ID: 30561818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Adjuvant Multimodality Therapy After Curative-Intent Resection of Ampullary Carcinoma.
    Ecker BL; Vollmer CM; Behrman SW; Allegrini V; Aversa J; Ball CG; Barrows CE; Berger AC; Cagigas MN; Christein JD; Dixon E; Fisher WE; Freedman-Weiss M; Guzman-Pruneda F; Hollis RH; House MG; Kent TS; Kowalsky SJ; Malleo G; Salem RR; Salvia R; Schmidt CR; Seykora TF; Zheng R; Zureikat AH; Dickson PV
    JAMA Surg; 2019 Aug; 154(8):706-714. PubMed ID: 31141112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of pathologic response to preoperative therapy in pancreatic cancer.
    Chun YS; Cooper HS; Cohen SJ; Konski A; Burtness B; Denlinger CS; Astsaturov I; Hall MJ; Hoffman JP
    Ann Surg Oncol; 2011 Dec; 18(13):3601-7. PubMed ID: 21947697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver perfusion chemotherapy for selected patients at a high-risk of liver metastasis after resection of duodenal and ampullary cancers.
    Noda T; Ohigashi H; Ishikawa O; Eguchi H; Yamada T; Sasaki Y; Yano M; Imaoka S
    Ann Surg; 2007 Nov; 246(5):799-805. PubMed ID: 17968172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of tumour location after adjuvant chemoradiotherapy for periampullary adenocarcinoma.
    Kim K; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
    Clin Transl Oncol; 2012 May; 14(5):391-5. PubMed ID: 22551547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?
    Mansour JC; Tang L; Shah M; Bentrem D; Klimstra DS; Gonen M; Kelsen DP; Brennan MF; Coit DG
    Ann Surg Oncol; 2007 Dec; 14(12):3412-8. PubMed ID: 17909917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of pathologic subtype in curatively resected ampulla of vater cancer.
    Kim WS; Choi DW; Choi SH; Heo JS; You DD; Lee HG
    J Surg Oncol; 2012 Mar; 105(3):266-72. PubMed ID: 21882202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumors of the ampulla of vater: histopathologic classification and predictors of survival.
    Carter JT; Grenert JP; Rubenstein L; Stewart L; Way LW
    J Am Coll Surg; 2008 Aug; 207(2):210-8. PubMed ID: 18656049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ampullary and periampullary adenocarcinoma: new challenges in management of recurrence.
    Ramfidis VS; Syrigos KN; Saif MW
    JOP; 2013 Mar; 14(2):158-60. PubMed ID: 23474562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing lymph node metastasis in patients with ampullary adenocarcinoma.
    Okano K; Asano E; Kushida Y; Kamada H; Mori H; Suzuki Y
    Dig Surg; 2014; 31(6):459-67. PubMed ID: 25613423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathologic T1 subclassification of ampullary carcinoma with perisphincteric or duodenal submucosal invasion: Is it T1b?
    You D; Heo J; Choi S; Choi D; Jang KT
    Arch Pathol Lab Med; 2014 Aug; 138(8):1072-6. PubMed ID: 25076296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Nomogram for Disease-Specific Survival in Patients with Non-metastatic Ampullary Carcinoma After Surgery.
    Li HB; Zhao FQ; Zhou J
    Ann Surg Oncol; 2019 Apr; 26(4):1079-1085. PubMed ID: 30659390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transduodenal local resection for low-risk group ampulla of vater carcinoma.
    Park JS; Yoon DS; Park YN; Lee WJ; Chi HS; Kim BR
    J Laparoendosc Adv Surg Tech A; 2007 Dec; 17(6):737-42. PubMed ID: 18158802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ampullary cancer and preoperative jaundice: possible indication of the minimal surgery.
    Uchida H; Shibata K; Iwaki K; Kai S; Ohta M; Kitano S
    Hepatogastroenterology; 2009; 56(93):1194-8. PubMed ID: 19760968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Recurrence and Omission of Adjuvant Therapy after Pancreaticoduodenectomy Argue against a Surgery-First Approach.
    Xia BT; Habib DA; Dhar VK; Levinsky NC; Kim Y; Hanseman DJ; Sutton JM; Wilson GC; Smith M; Choe KA; Sussman JJ; Ahmad SA; Abbott DE
    Ann Surg Oncol; 2016 Dec; 23(13):4156-4164. PubMed ID: 27459987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.